Clinical Trial Update: A Study of AK0529 in Chinese Infants Hospitalized With RSV [Phase 3]

View source ↗

Summary

Phase 3 trial update for AK0529 in Chinese infants hospitalized with Respiratory Syncytial Virus infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infections

Drugs mentioned

• AK0529 (AK0529)

Snippet

Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd. | Conditions: Respiratory Syncytial Virus Infections | Phase 3 | Status: COMPLETED